ConductScience.org, home

Trial · NCT02607722

Adverse events448

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherDiarrhoeaGastrointestinal disordersIPF Patients Receiving Nintedanib2,0365,734
otherNauseaGastrointestinal disordersIPF Patients Receiving Nintedanib3475,734
otherHepatic function abnormalHepatobiliary disordersIPF Patients Receiving Nintedanib8295,734
otherLiver disorderHepatobiliary disordersIPF Patients Receiving Nintedanib4375,734
otherDecreased appetiteMetabolism and nutrition disordersIPF Patients Receiving Nintedanib5795,734
seriousAcquired haemophiliaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib15,734
seriousAgranulocytosisBlood and lymphatic system disordersIPF Patients Receiving Nintedanib15,734
seriousAnaemiaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib55,734
seriousAutoimmune haemolytic anaemiaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib15,734
seriousBlood loss anaemiaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib15,734
seriousDisseminated intravascular coagulationBlood and lymphatic system disordersIPF Patients Receiving Nintedanib75,734
seriousFebrile neutropeniaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib75,734
seriousHaemolytic anaemiaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib15,734
seriousImmune thrombocytopeniaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib25,734
seriousMyelosuppressionBlood and lymphatic system disordersIPF Patients Receiving Nintedanib15,734
seriousThrombocytopeniaBlood and lymphatic system disordersIPF Patients Receiving Nintedanib45,734
seriousAcute myocardial infarctionCardiac disordersIPF Patients Receiving Nintedanib65,734
seriousAngina pectorisCardiac disordersIPF Patients Receiving Nintedanib25,734
seriousAngina unstableCardiac disordersIPF Patients Receiving Nintedanib15,734
seriousAortic valve incompetenceCardiac disordersIPF Patients Receiving Nintedanib25,734

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02607722/events